Patent · US Active

Chaperonin 10 variants

US8933033B2 · kind B2 · utility

4Cited by

5References

16Claims

0Family size

Assignee

CBIO LIMITED · AU

Inventors

Dean Jason Naylor · Forsayth, AU
Richard James Brown · Brisbane, AU
Christopher Bruce Howard · Calle de la Era, AU
Christopher John De Bakker · Margate, AU
Jeanette Elizabeth Stok · Brisbane, AU
Andrew Leigh James · Ipswich, AU
Daniel Scott Lambert · Bairnsdale, AU
Kylie Jane Ralston · Newcastle, AU
Walter Rene Antonius Van Heumen · Ipswich, AU
Linda Allison Ward · Forsayth, AU

Key dates

Filing date	Oct 8, 2010
Grant date	Jan 13, 2015
Priority date	—
Expiry date	Feb 22, 2031

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates generally to chaperonin 10 N-terminal variants. More specifically, the invention relates to chaperonin 10 N-terminal variants with enhanced immunomodulatory capacity and/or enhanced binding affinity for pathogen-associated molecular patterns (PAMPs) and/or damage-associated molecular patterns (DAMPs).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.